Регулярно. Как приручить непослушный кишечник и достичь внутренней гармонии

8. Robayo-Torres CC, Opekun AR, Quezada-Calvillo R, et al. 13C-breath tests for sucrose digestion in congenital sucrase isomaltase-deficient and sacrosidase-supplemented patients. J Pediatr Gastroenterol Nutr. 2009;48(4):412–418.

9. Sanders SW, Tolmac KG, Reitberg DP. Effect of a single dose of lactase on symptoms and expired hydrogen after lactose challenge in lactose-intolerant subjects. Clin Pharm. 1992;11(6):533–538.

Глава 6

1. Apte MV, Wilson JS, Korsten MA. Alcohol-related pancreatic damage: Mechanisms and treatment. Alcohol Health Res World. 1997;21(1):13–20.

2. Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16(24):2978–2990.

3. Camilleri M, Vijayvargiya P. The role of bile acids in chronic diarrhea. Am J Gastroenterol. 2020;115(10):1596–1603.

4. Camilleri M. Bile acid diarrhea: Prevalence, pathogenesis, and therapy. Gut Liver. 2015;9(3):332–339. doi:10.5009/gnl14397.

5. Chedid V, Dhalla S, Clarke JO, et al. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med. 2014;3(3):16–24.

6. Choung RS, Ditah IC, Nadeau AM, et al. Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: Findings from the National Health and Nutrition Examination surveys from 1988 to 2012. Am J Gastroenterol. 2015;110(3):455–461.

7. Gottlieb K, Wacher V, Sliman J, Pimentel M. Review article: Inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders. Aliment Pharmacol Ther. 2016;43(2):197–212.

8. Häuser W, Musial F, Caspary WF, Stein J, Stallmach A. Predictors of irritable bowel-type symptoms and healthcare-seeking behavior among adults with celiac disease. Psychosom Med. 2007;69(4):370–376.

9. Krigel A, Turner KO, Makharia GK, Green PH, Genta RM, Lebwohl B. Ethnic variations in duodenal villous atrophy consistent with celiac disease in the United States. Clin Gastroenterol Hepatol. 2016;14(8):1105–1111.

10. Leite GGS, Weitsman S, Parodi G, et al. Mapping the segmental microbiomes in the human small bowel in comparison with stool: A REIMAGINE study. Dig Dis Sci. 2020;65(9):2595–2604.

11. Meijer C, Shamir R, Szajewska H, Mearin L. Celiac disease prevention. Front Pediatr. 2018;6:368.

12. Monash University FODMAP Diet app. Version 3.0.8 (434). Monash University.

13. Muskal SM, Sliman J, Kokai-Kun J, Pimentel M, Wacher V, Gottlieb K. Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway. F1000Res. 2016 Apr;5:606.

14. Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical guideline: Small intestinal bacterial overgrowth. Am J Gastroenterol. 2020;115(2):165–178.

15. Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: The North American consensus. Am J Gastroenterol. 2017;112(5):775–784.

16. Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: Antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2013;38(8):925–934.

17. Smolka AJ, Schubert ML. Helicobacter pylori – induced changes in gastric acid secretion and upper gastrointestinal disease. Curr Top Microbiol Immunol. 2017;400:227–252.

18. Synthetic Biologics Inc. Synthetic biologics provides update on investigatorsponsored phase 2b clinical study of SYN-010 in IBS-C patients. Available at www.prnewswire.com/news-releases/synthetic-biologics-provides-update-on-investigator-sponsored-phase-2b-clinical-study-of-syn-010-in-ibs-c-patients-301144645.html. Accessed January 2, 2022.

19. Vici G, Camilletti D, Polzonetti V. Possible role of vitamin D in celiac disease onset. Nutrients. 2020 Apr;12(4):1051. doi:10.3390/nu12041051.

20. Vijayvargiya P, Camilleri M. Update on bile acid malabsorption: Ready for prime time? Curr Gastroenterol Rep. 2018;20(3):10.

21. Vijayvargiya P, Gonzalez Izundegui D, Calderon G, Tawfic S, Batbold S, Camilleri M. Fecal bile acid testing in assessing patients with chronic unexplained diarrhea: Implications for healthcare utilization. Am J Gastroenterol. 2020;115(7):1094–1102.

Глава 7

1. Chandan S, Mohan BP, Chandan OC, et al. Curcumin use in ulcerative colitis: Is it ready for prime time? A systematic review and meta-analysis of clinical trials. Ann Gastroenterol. 2020;33(1):53–58.

2. Dang X, Xu M, Liu D, Zhou D, Yang W. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL3 for active ulcerative colitis: A systematic review and meta-analysis. PLoS One. 2020;15(3):e0228846.

3. Griffin N, Grant LA, Anderson S, Irving P, Sanderson J. Small bowel MR enterography: Problem solving in Crohn’s disease. Insights Imaging. 2012;3(3):251–263.

4. Heerasing N, Thompson B, Hendy P, et al. Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn’s disease. Aliment Pharmacol Ther. 2017;45(5):660–669.